A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC

INTRODUCTION: The real-world effectiveness of combination treatment with cytotoxic chemotherapy and programmed cell death protein-1 or programmed death-ligand 1 inhibitor for NSCLC, especially for the elderly (aged ≥75 y) or those with poor performance status (≥2), has not been fully elucidated. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimoto, Daichi, Miura, Satoru, Yoshimura, Kenichi, Wakuda, Kazushige, Oya, Yuko, Haratani, Koji, Itoh, Shoichi, Uemura, Takehiro, Morinaga, Ryotaro, Takahama, Takayuki, Nakashima, Kazuhisa, Tachihara, Motoko, Saito, Go, Tanizaki, Junko, Otsubo, Kohei, Ikeda, Satoshi, Matsumoto, Hirotaka, Hara, Satoshi, Hata, Akito, Masuda, Takeshi, Yamamoto, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819387/
https://www.ncbi.nlm.nih.gov/pubmed/35146460
http://dx.doi.org/10.1016/j.jtocrr.2021.100265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819387/
https://www.ncbi.nlm.nih.gov/pubmed/35146460
http://dx.doi.org/10.1016/j.jtocrr.2021.100265

Ejemplares similares